menu toggle

Infographic: How cryogenic logistics overcome the low tolerance for deviations of cell and gene therapies

By Andrea Zobel

Screenshot 2023-03-20 144021
Screenshot 2023-03-20 144021

Cell and gene therapies (CGTs) are at the spearhead of biomedical research. Autologous and allogeneic cell, gene, and tissue therapies are transforming healthcare and are demonstrating dramatic results, with patients by far the biggest beneficiaries. However, CGTs come with unique logistic requirements that add complexity and risk to supply chains.

Access to advanced therapeutic medicinal products depends on product stability and a highly controlled supply chain to reach patients safely. In this infographic, discover World Courier’s cutting-edge logistics solutions that ensure product integrity at every step and safeguard patient access to these life-changing therapies.

Download the full infographic below.

Screenshot 2023-03-20 144021

Cold hard facts about cryogenic CGT logistics

Which critical challenges concerning cryogenic transportation and storage are organizations with CGTs in clinical trials currently facing? Take a deep dive in our white paper Cold hard facts about cryogenic cell and gene therapy logistics, and learn more about how you can mitigate risks and build robust logistics platforms that support the clinical development of these innovative therapies.




About The Author

Andrea Zobel
Senior Director, Personalized Supply Chain
World Courier
View Bio